Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Separately, the brand's site references published clinical-trial data for the drug class itself, stating that "tirzepatide and semaglutide have shown 15-20% body weight reduction in clinical trials." That figure describes the medication class in general clinical research - not Telos Rx's specific patient outcomes, and the two data points shouldn't be conflated
Zepbound injections: Another powerful tool in the fight against obesity, Zepbound injections help control hunger by influencing appetite-regulating hormones, offering patients a safe and effective way to shed pounds
Instead of relying only on food tracking or motivation alone, this program combines medical treatment with behavior change in a way that feels practical, human, and doable
Given that retatrutide already activates three receptor pathways, the marginal benefit of adding additional GLP-1 or GIP agonists is likely minimal or counterproductive
